2
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Conditions
Neoplasms
5
Polycythemia Vera
4
Lung Neoplasms
4
Ovarian Neoplasms
3
Myeloproliferative Disorders
3
Colorectal Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Breast Neoplasms
3
Prostatic Neoplasms
2
Lymphoma
2
Head and Neck Neoplasms
2
Carcinoma, Squamous Cell
2
Brain Neoplasms
2
Adenocarcinoma
2
Urticaria
1
Tuberous Sclerosis
1
Thymic aplasia
1
Thrombosis
1
Squamous Cell Carcinoma of Head and Neck
1
Smoking
1
Small Cell Lung Carcinoma
1
Severe Combined Immunodeficiency
1
Sarcoma
1
Salivary Gland Neoplasms
1
Renal Insufficiency, Chronic
1
Rectal Neoplasms
1
Primary Dysautonomias
1
Polycythemia
1
Polycystic Ovary Syndrome
1
Pancreatitis, Chronic
1
Interventions
Gemcitabine
5
Albumin-Bound Paclitaxel
4
130-nm albumin-bound paclitaxel
4
selpercatinib
2
niraparib
2
napabucasin
2
entinostat
2
Ocoxin
2
Irinotecan
2
Bevacizumab
2
temsirolimus
1
tariquidar
1
repotrectinib
1
pralsetinib
1
pembrolizumab
1
lutetium Lu 177 dotatate
1
irinotecan sucrosofate
1
ganitumab
1
copper dotatate CU-64
1
Valproic Acid
1
Trabectedin
1
Therapeutic Irrigation
1
Taxes
1
Sunitinib
1
Staining and Labeling
1
Sirolimus
1
Psilocybin
1
Phlebotomy
1
Paclitaxel
1
Oxaliplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Endocrine Gland Neoplasms
×
Phlebotomy
×
Clear all
NCT07121998
2025-08-14
PROGRESS-TMZ
Uppsala University
Recruiting
94 enrolled